{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:32:25Z","timestamp":1791340345557,"version":"4.3.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do estado de S\u00e3o Paulo - FAPESP","award":["#2009\/51897-5"],"award-info":[{"award-number":["#2009\/51897-5"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (BR)","doi-asserted-by":"publisher","award":["#301411\/2009-3"],"award-info":[{"award-number":["#301411\/2009-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Grant Frederico Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-0949-6","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T06:02:28Z","timestamp":1456293748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["IL-23\/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Fernanda Manente","family":"Milanez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla G. S.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma T.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio C. B.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory Vin\u00edcius","family":"P\u00e9rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percival Degrava","family":"Sampaio-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lio R.","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00edsa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"949_CR1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2013.06.010","volume":"57","author":"JP Sherlock","year":"2014","unstructured":"Sherlock JP, Buckley CD, Cua DJ. The critical role of interleukin-23 in spondyloarthropathy. Mol Immunol. 2014;57:38\u201343.","journal-title":"Mol Immunol."},{"key":"949_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","volume":"57","author":"HS Hreggvidsdottir","year":"2014","unstructured":"Hreggvidsdottir HS, Noordenbos T, Baeten DL. Inflammatory pathways in spondyloarthritis. Mol Immunol. 2014;57:28\u201337.","journal-title":"Mol Immunol."},{"key":"949_CR3","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012;366:1190\u20139.","journal-title":"N Engl J Med."},{"key":"949_CR4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","volume":"366","author":"KA Papp","year":"2012","unstructured":"Papp KA, Leonardi C, Menter A, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366:1181\u20139.","journal-title":"N Engl J Med."},{"key":"949_CR5","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J, et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382:1705\u201313.","journal-title":"Lancet."},{"key":"949_CR6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy D, Hermann K-GA, Callhoff J, Listing J, Sieper J. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis. 2014;73:817\u201323.","journal-title":"Ann Rheum Dis."},{"key":"949_CR7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Wellcome Trust Case Control Consortium (WTCCC), Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329\u201337.","journal-title":"Nat Genet"},{"key":"949_CR8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna TJ, Davidson SI, Duan R, et al. Enrichmentof circulating interleukin-17-secreting interleukin-23 receptor-positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012;64:1420\u20139.","journal-title":"Arthritis Rheum."},{"key":"949_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","volume":"57","author":"RA Colbert","year":"2014","unstructured":"Colbert RA, Tran TM, Layh-Schmitt G. HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol. 2014;57:44\u201351.","journal-title":"Mol Immunol."},{"key":"949_CR10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","volume":"73","author":"FA Ciccia","year":"2014","unstructured":"Ciccia FA, Accardo-Palumbo A, Rizzo A, et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis. 2014;73:1566\u201374.","journal-title":"Ann Rheum Dis."},{"key":"949_CR11","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.30593","volume":"63","author":"L Zeng","year":"2011","unstructured":"Zeng L, Lindstrom MJ, Smith JA. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum. 2011;63:3807\u201317.","journal-title":"Arthritis Rheum."},{"key":"949_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","volume":"252","author":"LA Z\u00fa\u00f1iga","year":"2013","unstructured":"Z\u00fa\u00f1iga LA, Jain R, Haines C, Cua DJ. Th17 cell development: from the cradle to the grave. Immunol Rev. 2013;252:78\u201388.","journal-title":"Immunol Rev."},{"key":"949_CR13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","volume":"10","author":"MJ McGeachy","year":"2009","unstructured":"McGeachy MJ, Chen Y, Tato CM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin17-producing effector T helper cells in vivo. Nat Immunol. 2009;10:314\u201324.","journal-title":"Nat Immunol."},{"key":"949_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","volume":"26","author":"N Yeremenko","year":"2014","unstructured":"Yeremenko N, Paramarta JE, Baeten D. The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis. Curr Opin Rheumatol. 2014;26:361\u201370.","journal-title":"Curr Opin Rheumatol."},{"key":"949_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","volume":"66","author":"JA Smith","year":"2014","unstructured":"Smith JA, Colbert RA. Review: The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheumatol. 2014;66:231\u201341.","journal-title":"Arthritis Rheumatol."},{"key":"949_CR16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1189\/jlb.0310139","volume":"88","author":"MC Gagliardi","year":"2010","unstructured":"Gagliardi MC, Teloni R, Mariotti S, et al. Endogenous PGE2 promotes the induction of human Th17 responses by fungal \u03b2-glucan. J Leukoc Biol. 2010;88:947\u201354.","journal-title":"J Leukoc Biol."},{"key":"949_CR17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","volume":"2","author":"KA Blackwell","year":"2010","unstructured":"Blackwell KA, Raisz LG, Pilbeam CC. Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab. 2010;2:294\u2013301.","journal-title":"Trends Endocrinol Metab."},{"key":"949_CR18","doi-asserted-by":"crossref","first-page":"e87706","DOI":"10.1371\/journal.pone.0087706","volume":"9","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wang JH. Prostaglandin E2 (PGE2) exerts biphasic effects on human tendon stem cells. PLoS One. 2014;9:e87706.","journal-title":"PLoS One."},{"key":"949_CR19","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","volume":"58","author":"D Heijde van der","year":"2008","unstructured":"van der Heijde D, Landew\u00e9 R, Baraliakos X, et al. Radiographic findigs following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008;58:3063\u201370.","journal-title":"Arthritis Rheum."},{"key":"949_CR20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","volume":"58","author":"D Heijde van der","year":"2008","unstructured":"van der Heijde D, Landew\u00e9 R, Einstein S, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum. 2008;58:1324\u201331.","journal-title":"Arthritis Rheum."},{"key":"949_CR21","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","volume":"11","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Salonen D, Weissman BN, et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up 2\u00a0years. Arthrtis Res Ther. 2009;11:R127.","journal-title":"Arthrtis Res Ther."},{"key":"949_CR22","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, Dv H, Landew\u00e9 R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756\u201365.","journal-title":"Arthritis Rheum."},{"key":"949_CR23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis inception cohort. Ann Rheum Dis. 2012;71:1616\u201322.","journal-title":"Ann Rheum Dis."},{"key":"949_CR24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.37937","volume":"65","author":"H Appel","year":"2013","unstructured":"Appel H, Maier R, Bleil J, et al. In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis. Arthritis Rheum. 2013;65:1522\u20139.","journal-title":"Arthritis Rheum."},{"key":"949_CR25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t\u2009+\u2009CD3+ CD4\u2013CD8\u2013 entheseal resident T cells. Nat Med. 2012;18:1069\u201376.","journal-title":"Nat Med."},{"key":"949_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"key":"949_CR27","first-page":"905","volume":"2011","author":"SJ Heijde van der","year":"2010","unstructured":"van der Heijde SJ, Maksymowych WP, Dougados M, et al. Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis. 2010;2011:905\u20138.","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 2","key":"949_CR28","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl 2:ii1\u201344.","journal-title":"Ann Rheum Dis"},{"key":"949_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2010.133488","volume":"70","author":"M Dougados","year":"2011","unstructured":"Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 2011;70:249\u201351.","journal-title":"Ann Rheum Dis."},{"key":"949_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, et al. Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70:47\u201353.","journal-title":"Ann Rheum Dis."},{"key":"949_CR31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers MC, Franssen MJ, van\u2019t Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005;64:127\u20139.","journal-title":"Ann Rheum Dis."},{"key":"949_CR32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","volume":"75","author":"WS Chen","year":"2012","unstructured":"Chen WS, Chang YS, Lin KC, et al. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chin Med Assoc. 2012;75:303\u20138.","journal-title":"J Chin Med Assoc."},{"key":"949_CR33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Lin Z, Wei Q, Jiang Y, Gu J. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int. 2009;29:1343\u20137.","journal-title":"Rheumatol Int."},{"key":"949_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"30","author":"Y Mei","year":"2011","unstructured":"Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30:269\u201373.","journal-title":"Clin Rheumatol."},{"key":"949_CR35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2009.107649","volume":"69","author":"L Melis","year":"2010","unstructured":"Melis L, Vandooren B, Kruithof E, et al. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis. 2010;69:618\u201323.","journal-title":"Ann Rheum Dis."},{"key":"949_CR36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/03009742.2014.956142","volume":"44","author":"SH Sveaas","year":"2015","unstructured":"Sveaas SH, Berg IJ, Provan SA, et al. Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study. Scand J Rheumatol. 2015;44:118\u201324.","journal-title":"Scand J Rheumatol."},{"key":"949_CR37","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1002\/art.30600","volume":"63","author":"JS Gaston","year":"2011","unstructured":"Gaston JS, Goodall JC, Baeten D. Interleukin-23: a central cytokine in the pathogenesis of spondylarthritis. Arthritis Rheum. 2011;63:3668\u201371.","journal-title":"Arthritis Rheum."},{"key":"949_CR38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","volume":"60","author":"F Ciccia","year":"2009","unstructured":"Ciccia F, Bombardieri M, Principato A, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 2009;60:955\u201365.","journal-title":"Arthritis Rheum."},{"key":"949_CR39","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1073\/pnas.062053399","volume":"99","author":"K Yoshida","year":"2002","unstructured":"Yoshida K, Oida H, Kobayashi T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A. 2002;99:4580\u20135.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"949_CR40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00264-007-0406-x","volume":"31","author":"M Li","year":"2007","unstructured":"Li M, Thompson DD, Paralkar VM. Prostaglandin E(2) receptors in bone formation. Int Orthop. 2007;31:767\u201372.","journal-title":"Int Orthop."},{"key":"949_CR41","doi-asserted-by":"crossref","first-page":"e74794","DOI":"10.1371\/journal.pone.0074794","volume":"19","author":"W Chai","year":"2013","unstructured":"Chai W, Lian Z, Chen C, et al. JARID1A, JMY, and PTGER4 polymorphisms are related to ankylosing spondylitis in Chinese Han patients: a case-control study. PLoS One. 2013;19:e74794.","journal-title":"PLoS One."},{"issue":"7","key":"949_CR42","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/annrheumdis-2013-204835","volume":"74","author":"A Cortes","year":"2015","unstructured":"Cortes A, Maksymowych WP, Wordsworth BP, et al. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis. Ann Rheum Dis. 2015;74(7):1387-93. doi: 10.1136\/annrheumdis-2013-204835 . Epub 2014 Mar 20.","journal-title":"Ann Rheum Dis"},{"key":"949_CR43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11:763\u201376.","journal-title":"Nat Rev Drug Discov."},{"key":"949_CR44","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"Bowness P, Ridley A, Shaw J, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol. 2011;186:2672\u201380.","journal-title":"J Immunol."},{"issue":"1","key":"949_CR45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","volume":"74","author":"S Ramiro","year":"2015","unstructured":"Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015;74(1):52-9. doi: 10.1136\/annrheumdis-2013-204055 . Epub 2013 Aug 16.","journal-title":"Ann Rheum Dis"},{"key":"949_CR46","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.080871","volume":"36","author":"X Baraliakos","year":"2009","unstructured":"Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitis\u2014evidence for major individual variations in a large proportion of patients. J Rheumatol. 2009;36:997\u20131002.","journal-title":"J Rheumatol."},{"key":"949_CR47","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2012;64:1388\u201398.","journal-title":"Arthritis Rheum."},{"key":"949_CR48","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, et al. The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65:2645\u201354.","journal-title":"Arthritis Rheum."},{"key":"949_CR49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrrheum.2013.123","volume":"9","author":"WP Maksymowych","year":"2013","unstructured":"Maksymowych WP. Spondyloarthritis. Treat-to-target in spondyloarthritis\u2014do we have a plan? Nat Rev Rheumatol. 2013;9:507\u20138.","journal-title":"Nat Rev Rheumatol"},{"key":"949_CR50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73:6\u201316.","journal-title":"Ann Rheum Dis."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-0949-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T15:27:44Z","timestamp":1718378864000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.com\/content\/18\/1\/52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["949"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-0949-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"article-number":"52"}}